These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5241484)

  • 1. The relationship of treatment to weight in a randomized study of maturity-onset diabetes.
    Meinert CL; Schwartz TB
    Ann N Y Acad Sci; 1968 Mar; 148(3):875-83. PubMed ID: 5241484
    [No Abstract]   [Full Text] [Related]  

  • 2. The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy.
    Diabetes; 1975; 24 Suppl 1():65-184. PubMed ID: 1090475
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
    Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
    JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of hypoglycemic agents on blood lipids and body weight in ketoacidosis-resistant diabetics.
    Gershberg H; Javier Z; Hulse M; Hecht A
    Ann N Y Acad Sci; 1968 Mar; 148(3):914-24. PubMed ID: 4968572
    [No Abstract]   [Full Text] [Related]  

  • 5. Farewell to phenformin for treating diabetes mellitus.
    Williams RH; Palmer JP
    Ann Intern Med; 1975 Oct; 83(4):567-8. PubMed ID: 1166991
    [No Abstract]   [Full Text] [Related]  

  • 6. The crux of the UGDP. Spurious results and biologically inappropriate data analysis.
    Kilo C; Miller JP; Williamson JR
    Diabetologia; 1980 Mar; 18(3):179-85. PubMed ID: 6989693
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of phenformin hydrochloride on serum cholesterol and triglyceride levels of the stable adult diabetic.
    Schwartz MJ; Mirsky S; Schaefer LE
    Metabolism; 1966 Sep; 15(9):808-22. PubMed ID: 5929037
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progress in diabetes therapy using glibenclamide and phenformin. Report from the years 1967-1970 on 323 patients].
    Beyer J; Ewald W; Kunkel W; Wolf E; Schöffling K
    Dtsch Med Wochenschr; 1971 Apr; 96(17):728-33. PubMed ID: 5552854
    [No Abstract]   [Full Text] [Related]  

  • 9. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Polosa P; Mughini L
    Minerva Med; 1974 Aug; 65(59):383-9. PubMed ID: 4213556
    [No Abstract]   [Full Text] [Related]  

  • 10. Combinations of oral hypoglycemic drugs in obese, insulin-resistant diabetics.
    Fineberg SK
    Geriatrics; 1968 Sep; 23(9):137-46. PubMed ID: 5673663
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Oral hypoglycaemics in diabetes mellitus.
    Keen H; Jarrett RJ; Fuller JH
    Lancet; 1975 Nov; 2(7940):865. PubMed ID: 53342
    [No Abstract]   [Full Text] [Related]  

  • 12. [The venture of University Group Diabetes Program (UGDP). Some personal reflexions. Tolbutamide and phenformin under accusation].
    Pirart J
    Nouv Presse Med; 1972 Jan; 1(5):325-8. PubMed ID: 5010448
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenformin effect on body weight, lipids, and glucose regulation.
    Alterman SL; Lopez-Gomez AA
    Ann N Y Acad Sci; 1968 Mar; 148(3):884-91. PubMed ID: 4872312
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of phenformin on peripheral glucose utilization and insulin action in obesity and diabetes mellitus.
    Butterfield WJ
    Ann N Y Acad Sci; 1968 Mar; 148(3):724-33. PubMed ID: 5242146
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical testing of Tolbutaphen in the treatment of adult diabetes].
    Schneider J; Kaffarnik H
    Z Allgemeinmed; 1975 Jan; 51(2):74-5. PubMed ID: 766424
    [No Abstract]   [Full Text] [Related]  

  • 16. Homeostasis of body weight in a diabetes clinic population.
    Goodner CJ; Ogilvie JT
    Diabetes; 1974 Apr; 23(4):318-26. PubMed ID: 4207366
    [No Abstract]   [Full Text] [Related]  

  • 17. The UGDP--tolbutamide and mortality.
    Knowles HC
    Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of phenformin and metformin in the treatment of maturity onset diabetes.
    Cairns SA; Shalet S; Marshall AJ; Hartog M
    Diabete Metab; 1977 Sep; 3(3):183-8. PubMed ID: 913750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents.
    JAMA; 1975 Feb; 231(6):583-608. PubMed ID: 1089822
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of diagnostic criteria on the mortality findings in the University Group Diabetic Programme study of diabetic therapy.
    Gray RH
    Med J Aust; 1973 Mar; 1(12):594-6. PubMed ID: 4573383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.